I sat and watched this piece off N-TV here in Germany in the last hour, and it's an interesting twist on the Covid-19 virus.
Charité Hospital in Berlin, is one of the most noted hospitals in the world on research.
So it's come out that they are testing the use of tapeworm against the virus.
The deal is this....you'd normally use this tapeworm drug niclosamide....which runs between 15 and 35 Euro (depending on which company makes it). It's very effective on tapeworm.
What they found was that there is this experimental cancer drug....which if you combine it with niclosamide....it reduces the production of infectious Covid particles by roughly 99-percent.
This cancer drug? MK-2206. It's been around for a decade. It was intended to be used when cancers reached a point where normal therapy drugs were not effective.
Path ahead? More research. No one is saying this will be a produced therapy in 2021.
First use of the tapeworm drug? No....actually it was talked about in the summer of 2020 by a Danish team working on a Covid-19 product.
No comments:
Post a Comment